Utilisation of Lipid-Lowering Drugs in Spain between 1986 and 1998
Authors: Carvajal A.1; del Pozo J.G.1; Rodríguez M.B.1; Martín Arias L.H.1; de Castro A.M.R.1
Source: Clinical Drug Investigation, Volume 20, Number 3, 1 September 2000 , pp. 197-201(5)
Publisher: Adis International
Key:
- Free Content
- New Content
- Subscribed Content
- Free Trial Content
Abstract:
Objective: To investigate the pattern of use of lipid-lowering drugs in Spain between 1986 and 1998, with particular emphasis on the impact of drug utilisation following the marketing of statins in Spain.Design: Information on drug utilisation was obtained from the ECOM (Especialidades Consumo de Medicamentos) database of the Spanish Ministry of Health, which contains the number of packages sold in community pharmacies and charged to the National Health System. Data were expressed in defined daily doses (DDD) per 1000 inhabitants per day.Main Outcomes and Results: The use of lipid-lowering drugs increased from 2.45 DDD/1000 inhabitants/day (1986) to more than 19.3 DDD/1000 inhabitants/ day (1998). Over the period studied, fibrates (until 1995), and statins (thereafter), were the most widely used lipid-lowering drugs. The consumption of probucol and other lipid-lowering drugs, including fixed-dose combinations, decreased during this period.Conclusion: The consumption of lipid-lowering drugs has increased dramatically in Spain during the last few years. This increase did not seem to be directly influenced by the information derived from important clinical trials. The introduction of statins has markedly modified the pattern of use of lipid-lowering drugs in Spain. Some indicators point to a greater rationality in the consumption of these drugs.Keywords: Antihyperlipidaemics, therapeutic use; Drug utilisation; Hyperlipidaemia, treatment; Pharmacoeconomics
Document Type: Original article
Affiliations: 1: Instituto de Farmacoepidemiología, Universidad de Valladolid, Valladolid, Spain
Key:
- Free Content
- New Content
- Subscribed Content
- Free Trial Content

Click here for Page Help